• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动脉瓣疾病中的C反应蛋白

C-reactive protein in aortic valve disease.

作者信息

Sanchez Pedro L, Mazzone Anna Maria

机构信息

Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario de Valladolid, C/Ramón y Cajal, 47005, Valladolid, Spain.

出版信息

Cardiovasc Ultrasound. 2006 Oct 16;4:37. doi: 10.1186/1476-7120-4-37.

DOI:10.1186/1476-7120-4-37
PMID:17042945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1618858/
Abstract

Aortic Valve Disease, includes a range of disorder severity from mild leaflet thickening without valve obstruction, "aortic sclerosis", to severe calcified aortic stenosis. It is a slowly progressive active process of valve modification similar atherosclerosis for cardiovascular risk factors, lipoprotein deposition, chronic inflammation, and calcification. Systemic signs of inflammation, as wall and serum CRP, similar to those found in atherosclerosis, are present in patients with degenerative aortic valve stenosis and may be expression of a common disease, useful in monitoring of stenosis progression.

摘要

主动脉瓣疾病包括一系列严重程度不同的病症,从无瓣膜梗阻的轻度瓣叶增厚(“主动脉瓣硬化”)到严重的钙化性主动脉瓣狭窄。它是一个缓慢进展的主动瓣膜改变过程,类似于心血管危险因素、脂蛋白沉积、慢性炎症和钙化导致的动脉粥样硬化。与动脉粥样硬化中发现的情况类似,退行性主动脉瓣狭窄患者存在全身炎症体征,如壁和血清中的CRP,这可能是一种常见疾病的表现,有助于监测狭窄进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b5f/1618858/f3a0a91377d6/1476-7120-4-37-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b5f/1618858/e75d1cc25593/1476-7120-4-37-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b5f/1618858/f3a0a91377d6/1476-7120-4-37-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b5f/1618858/e75d1cc25593/1476-7120-4-37-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b5f/1618858/f3a0a91377d6/1476-7120-4-37-2.jpg

相似文献

1
C-reactive protein in aortic valve disease.主动脉瓣疾病中的C反应蛋白
Cardiovasc Ultrasound. 2006 Oct 16;4:37. doi: 10.1186/1476-7120-4-37.
2
C-reactive protein in degenerative aortic valve stenosis.退行性主动脉瓣狭窄中的C反应蛋白
Cardiovasc Ultrasound. 2006 Jun 14;4:24. doi: 10.1186/1476-7120-4-24.
3
Correlation of high sensitivity C-reactive protein and calcific aortic valve disease.高敏C反应蛋白与钙化性主动脉瓣疾病的相关性
Mayo Clin Proc. 2007 Feb;82(2):171-4. doi: 10.4065/82.2.171.
4
Prognostic Value of hs-CRP After Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后高敏C反应蛋白的预后价值
Circ Cardiovasc Interv. 2018 Dec;11(12):e007213. doi: 10.1161/CIRCINTERVENTIONS.118.007213.
5
C-reactive protein is increased in patients with degenerative aortic valvular stenosis.退行性主动脉瓣狭窄患者的C反应蛋白升高。
J Am Coll Cardiol. 2001 Oct;38(4):1078-82. doi: 10.1016/s0735-1097(01)01484-x.
6
Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.脂蛋白(a)是外周动脉疾病主动脉瓣和二尖瓣狭窄的一个危险因素。
Eur Heart J Cardiovasc Imaging. 2016 May;17(5):492-7. doi: 10.1093/ehjci/jev338. Epub 2016 Jan 12.
7
Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.接受经导管主动脉瓣置换术患者的脂蛋白(a)
Angiology. 2019 Apr;70(4):332-336. doi: 10.1177/0003319719826461. Epub 2019 Jan 30.
8
Epidemiology and cardiovascular risk factors of aortic stenosis.主动脉瓣狭窄的流行病学及心血管危险因素
Cardiovasc Ultrasound. 2006 Jul 1;4:27. doi: 10.1186/1476-7120-4-27.
9
Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.临床因素而非C反应蛋白可预测钙化性主动脉瓣疾病的进展:心血管健康研究
J Am Coll Cardiol. 2007 Nov 13;50(20):1992-8. doi: 10.1016/j.jacc.2007.07.064. Epub 2007 Oct 29.
10
[Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis].[主动脉瓣狭窄患者血清中骨保护素和核因子κB受体活化因子配体的浓度]
Kardiologiia. 2014;54(6):44-8. doi: 10.18565/cardio.2014.6.44-48.

引用本文的文献

1
Development and validation of a new prediction model for calcific aortic valve stenosis.一种用于钙化性主动脉瓣狭窄的新预测模型的开发与验证。
J Thorac Dis. 2022 Oct;14(10):4044-4054. doi: 10.21037/jtd-22-1157.
2
Impact of Oxidative Stress and Protein S-Glutathionylation in Aortic Valve Sclerosis Patients with Overt Atherosclerosis.氧化应激和蛋白质S-谷胱甘肽化对伴有明显动脉粥样硬化的主动脉瓣硬化患者的影响。
J Clin Med. 2019 Apr 24;8(4):552. doi: 10.3390/jcm8040552.
3
C-reactive protein and subclinical cardiovascular disease among African-Americans: (the Jackson Heart Study).

本文引用的文献

1
Relation of circulating C-reactive protein to progression of aortic valve stenosis.循环C反应蛋白与主动脉瓣狭窄进展的关系。
Am J Cardiol. 2006 Jan 1;97(1):90-3. doi: 10.1016/j.amjcard.2005.07.113. Epub 2005 Nov 10.
2
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.退行性主动脉瓣中的组织驻留C反应蛋白:与血清C反应蛋白浓度的相关性及他汀类药物的修饰作用
Heart. 2006 Apr;92(4):495-8. doi: 10.1136/hrt.2005.069815. Epub 2005 Sep 13.
3
Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
C 反应蛋白与非裔美国人亚临床心血管疾病:(杰克逊心脏研究)。
J Cardiovasc Med (Hagerstown). 2014 May;15(5):371-6. doi: 10.2459/JCM.0b013e32836411d6.
4
Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.钙化性主动脉瓣狭窄进展的危险因素及潜在治疗靶点。
Int J Angiol. 2008 Summer;17(2):63-70. doi: 10.1055/s-0031-1278283.
5
Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?糖尿病是否通过增强主动脉瓣内的炎症反应加速主动脉瓣狭窄的进展?
Inflammation. 2012 Jun;35(3):834-40. doi: 10.1007/s10753-011-9384-7.
6
Retraction: C-reactive protein in aortic valve disease.撤稿声明:主动脉瓣疾病中的C反应蛋白
Cardiovasc Ultrasound. 2006 Nov 8;4:42. doi: 10.1186/1476-7120-4-42.
阿托伐他汀通过低密度脂蛋白受体相关蛋白5(Lrp5)受体途径抑制高胆固醇血症诱导的主动脉瓣钙化。
Circulation. 2005 Aug 30;112(9 Suppl):I229-34. doi: 10.1161/01.CIRCULATIONAHA.104.524306.
4
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients.高钙磷乘积与血液透析患者的高C反应蛋白浓度相关。
Nephron Clin Pract. 2005;101(4):c161-7. doi: 10.1159/000087391. Epub 2005 Aug 9.
5
The functional role of C-reactive protein in aortic wall calcification.C反应蛋白在主动脉壁钙化中的功能作用。
Cardiology. 2005;104(2):57-64. doi: 10.1159/000086686. Epub 2005 Jul 5.
6
Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population.终末期肾病(ESRD)患者手术切除的心脏瓣膜与普通人群的心脏瓣膜比较。
Am J Kidney Dis. 2005 Jul;46(1):86-93. doi: 10.1053/j.ajkd.2005.03.020.
7
Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.钙化性主动脉瓣疾病的谱系:发病机制、疾病进展及治疗策略。
Circulation. 2005 Jun 21;111(24):3316-26. doi: 10.1161/CIRCULATIONAHA.104.486738.
8
Statins for aortic stenosis.用于治疗主动脉瓣狭窄的他汀类药物。
N Engl J Med. 2005 Jun 9;352(23):2441-3. doi: 10.1056/NEJMe058070.
9
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.一项关于钙化性主动脉瓣狭窄强化降脂治疗的随机试验。
N Engl J Med. 2005 Jun 9;352(23):2389-97. doi: 10.1056/NEJMoa043876.
10
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve.阿托伐他汀可抑制高胆固醇血症主动脉瓣钙化并增强一氧化氮合酶的生成。
Heart. 2005 Jun;91(6):806-10. doi: 10.1136/hrt.2003.029785.